Filing Details
- Accession Number:
- 0001209191-18-054598
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-09 18:42:01
- Reporting Period:
- 2018-10-04
- Accepted Time:
- 2018-10-09 18:42:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1446847 | Ironwood Pharmaceuticals Inc | IRWD | Pharmaceutical Preparations (2834) | 043404176 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1478244 | G Mark Currie | C/O Ironwood Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2018-10-04 | 40,556 | $11.25 | 70,680 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2018-10-04 | 34,479 | $11.11 | 105,159 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2018-10-04 | 41,615 | $10.24 | 146,774 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2018-10-04 | 94,456 | $17.94 | 52,318 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2018-10-04 | 22,194 | $18.75 | 30,124 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2018-10-05 | 40,556 | $11.25 | 70,680 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2018-10-05 | 34,480 | $11.11 | 105,160 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2018-10-05 | 41,615 | $10.24 | 146,775 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2018-10-05 | 116,651 | $17.53 | 30,124 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-10-04 | 40,556 | $0.00 | 40,556 | $11.25 |
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-10-04 | 34,479 | $0.00 | 34,479 | $11.11 |
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-10-04 | 41,615 | $0.00 | 41,615 | $10.24 |
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-10-05 | 40,556 | $0.00 | 40,556 | $11.25 |
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-10-05 | 34,480 | $0.00 | 34,480 | $11.11 |
| Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-10-05 | 41,615 | $0.00 | 41,615 | $10.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 49,444 | 2020-02-02 | No | 4 | M | Direct | |
| 75,521 | 2021-02-01 | No | 4 | M | Direct | |
| 193,385 | 2026-03-01 | No | 4 | M | Direct | |
| 8,888 | 2020-02-02 | No | 4 | M | Direct | |
| 41,041 | 2021-02-01 | No | 4 | M | Direct | |
| 151,770 | 2026-03-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class B Common Stock | 775,000 | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.37 to $18.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.37 to $19.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.22 to $17.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The option vested as to 1.25% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2010 for the first 36 months, and as to 4.5833% of the shares of Class A Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2014.
- The option, granted as an annual performance award, vested as to 1.25% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2011 for the first 36 months, and as to 4.5833% of the shares of Class A Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2015.
- The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2016.
Billionaire Hedge Funds
